Every story in this section, newest first — page 258 of 373.
Build-A-Bear Workshop (NYSE:BBW) announced record-breaking financial results for the fiscal year ended January 31, 2026, marking the highest annual revenue in the company’s history.
Dollar General (NYSE:DG) delivered a strong finish to its fiscal year 2025, posting fourth-quarter results that significantly outpaced the prior year's performance.
Aurora Mobile (NASDAQ:JG) reported a transformative performance for the fourth quarter and full year 2025, marking the company’s first-ever full year of GAAP profitability since its inception.
Full Truck Alliance Company (NYSE:YMM) released its unaudited fourth-quarter and full-year 2025 financial results on Thursday, revealing a year of high-margin growth and increased platform efficiency.
Xunlei (NASDAQ:XNET) released its unaudited fourth-quarter and full-year 2025 financial results on Thursday, revealing a year of explosive top-line expansion and a substantial non-operating windfall.
McEwen Mining (NYSE:MUX) reported a sharp return to profitability for the fourth quarter and full year 2025, driven by higher realized prices and operational efficiencies.
EHang Holdings (NASDAQ:EH) reached a historic financial turning point in the fourth quarter of 2025, reporting its first profitable period on a GAAP basis.
Here Group (NASDAQ:HERE) reported unaudited financial results for the second quarter of fiscal year 2026, covering the period from October to December 2025.
ProFrac Holding (NASDAQ:ACDC) reported its full-year and fourth-quarter 2025 financial results on Thursday, reflecting a challenging year for the hydraulic fracturing service provider characterized by lower overall demand and a strategic reduction in capital spending.
Futu Holdings (NASDAQ:FUTU) delivered a powerhouse financial performance for the full year 2025, driven by a global surge in retail trading activity and a significant expansion of its wealth management ecosystem.
Li Auto (NASDAQ:LI) released its unaudited fourth-quarter and full-year 2025 financial results on Thursday, revealing a year defined by heavy investment and a significant transition in its vehicle portfolio.
Stoneridge (NYSE:SRI) reported mixed results for the full year 2025, highlighting a deep divide between the rapid growth of its next-generation technology and legacy asset write-downs.
Uber Technologies (NYSE:UBER), Nissan Motor Company, and Wayve announced a strategic collaboration on Thursday to develop and deploy robotaxi services, marking Uber’s first autonomous vehicle partnership in the Japanese market.
Firefly Aerospace (NASDAQ:FLY) achieved a major operational milestone on Wednesday with the successful launch of its Alpha Flight 7 mission, dubbed "Stairway to Seven."
Cemex (NYSE:CX) announced a major restructuring of its South American footprint on Thursday, confirming agreements to divest several Colombian assets for a combined total of approximately $555 million.
Pharming Group (NASDAQ:PHAR) reported a significant shift in its financial trajectory for the full year 2025, posting total revenues of $376.1 million, a 27% increase over the previous year.
REGENXBIO (NASDAQ:RGNX) shared positive interim data from its Phase I/II AFFINITY DUCHENNE trial on Wednesday, bolstering the case for its gene therapy candidate, RGX-202.
Uber Technologies (NYSE:UBER) announced a multi-year strategic partnership with Zoox on Wednesday to deploy the startup's purpose-built robotaxis on its global ride-hailing network.
WisdomTree (NYSE:WT) reported record global assets under management (AUM) of approximately $159 billion for February 2026, driven by robust demand for its exchange-traded products and tokenized assets.
ATRenew (NYSE:RERE), a leading pre-owned electronics technology laboratory and trading platform in China, reported unaudited financial results for the fourth quarter and full year ended December 31, 2025.
CVS Health's (NYSE:CVS) insurance unit, Aetna, has agreed to pay $117.7 million to resolve allegations that it defrauded the U.S. government by submitting inaccurate diagnosis codes for Medicare Advantage enrollees.
Stryker (NYSE:SYK) shares dropped approximately 3% in Wednesday trading following a Wall Street Journal report that the medical device giant has been targeted by a suspected Iran-linked cyberattack.
Citius Oncology (NASDAQ:CTOR) reported positive topline results on Tuesday from an investigator-initiated Phase 1 clinical trial evaluating its flagship immunotherapy, LYMPHIR (denileukin diftitox-cxdl), in combination with Merck’s pembrolizumab (Keytruda).
Quoin Pharmaceuticals (NASDAQ:QNRX) announced on Wednesday that the U.S. Food and Drug Administration has granted Fast Track Designation to its QRX003 lotion (4%), a topical therapy aimed at treating Netherton Syndrome.
